Clinical trial
A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin…
NCT00001426 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001426 |
|---|---|
| Title | A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer |
| Official title | A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Neoplasm |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Paclitaxel, Cisplatin, G-CSF |
| Enrollment | 66 |
| Start date | Feb 3, 1995 |
| Primary completion | Oct 15, 2007 |
| Completion | Nov 7, 2013 |
| First posted | Nov 4, 1999 |
| Last update posted | Apr 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: